Arbutus Biopharma Corp. buy melinda
Start price
16.10.18
/
50%
€4.19
Target price
02.11.18
€6.31
Performance (%)
13.55%
End price
02.11.18
€4.76
Summary
This prediction ended on 02.11.18 with a price of €4.76. The BUY prediction by melinda finished with a performance of 13.55%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Arbutus Biopharma Corp. | -0.604% | -0.604% | 28.497% | 54.659% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
According to melinda what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
SecteurProduits pharmaceutiques Agenda 08/11 Publication de résultats
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection.
The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.
Nombre d'employés : 130 personnes.
Stopped prediction by melinda for Arbutus Biopharma Corp.
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.20
24.12.23
24.12.23
-
24.12.24
24.12.24
1.36%
06.01.24
06.01.24
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.03
08.07.23
08.07.23
-
08.07.24
08.07.24
-18.91%
26.11.23
26.11.23
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.14
06.01.20
06.01.20
-
20.05.20
20.05.20
-33.64%
20.05.20
20.05.20
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.73
03.06.19
03.06.19
€2.35
20.06.19
20.06.19
36.98%
20.06.19
20.06.19
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€6.55
21.10.17
21.10.17
€7.50
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€5.91
21.10.17
21.10.17
€6.77
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year